Comparison of Lanreotide Autogel® and Sandostatin LAR Depot in the Treatment of Clinical Symptoms Associated With Carcinoid Syndrome

This study has been terminated.

Study NCT00092287 Information provided by Ipsen

First Received: September 22, 2004 Last Updated: February 25, 2008 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been terminated.
Study Completion Date:	October 2004
Estimated Primary Completion Date:	No date given